Table 5 Comparison of median, 95% reference range and Mean ± SD of hematological parameters in this study and others
Parameter | Gondar (current study) | Addis Ababa [17] | Kenya [6] | Burkina Faso (22) | Wintrobe [2] | |||||
|---|---|---|---|---|---|---|---|---|---|---|
Median (95% range) | Mean ± SD | Median (95% range) | Mean ± SD | Median (95% range) | Mean ± SD | Median (95% range) | Mean ± SD | Median (95% range) | Mean ± SD | |
RBC (×1012) | ||||||||||
Female | 4.8 (3.45–6.25) | 4.7 ± 0.725 | 4.5 (3.7–5.2) | 4.5 ± 0.4 | 4.8 (3.7–5.6) | NA | 4.2 (3.5–4.9) | NA | NA (4.2–5.5) | 4.8 ± NA |
Male | 5.01 (3.53-6.93) | 0.09 ± 0.79 | 5 (4.3–5.9) | 5.1 ± 0.4 | 5.3 (4.4–6.3) | NA | 4.7 (3.8–5.6) | NA | NA (4.5–6.3) | 5.4 ± NA |
PCV (%) | ||||||||||
Female | 45.2 (32.1–56.6) | 44.2 ± 5.84 | 42.1 (35.3–48.8) | 42 ± 3.2 | 40 (30–50) | NA | 35 (30–39) | NA | NA (37–47) | 42 ± NA |
Male | 46.9 (36.2–58.6) | 6.8 ± 5.8 | 48.2 (41.6–55.11) | 48.3 ± 3.7 | 47 (40–50) | NA | 39 (34–46) | NA | NA (41–51) | 46 ± NA |
Hgb (g/dl) | ||||||||||
Female | 12.9 (11–16.7) | 13.2 ± 1.6 | 14.9 (12.2–16.6) | 14.3 ± 3.4 | 8.44 (5.9–10) | NA | 12 (9.8–13.5) | NA | NA (12–16) | 14 ± NA |
Male | 14.2 (11.5–18) | 14.4 ± 1.8 | 16.1 (13.9–18.3) | 16.1 ± 1.1 | 9.9 (8.3–11.3) | NA | 13.5 (11.3–15.6) | NA | NA (14–18) | 16 ± NA |
MCV (fl) | ||||||||||
Female | 92 ± 3.7 | NA | NA | 84.9 (66–95.7) | NA | 84 (75–92) | NA | NA | NA | |
Male | 92 (85 –100) | NA | NA | 88 (71.4–98.2) | NA | 85 (73–94) | NA | NA | NA | |
MCH (pg) | ||||||||||
Female | 28.6 (25.8–32.8) | 28.5 ± 1.46 | NA | NA | NA | NA | 28 (24–32) | NA | NA | NA |
Male | 29 (26.6–33.3) | 29.1 ± 1.54 | NA | NA | NA | NA | 29 (25–34) | NA | NA | NA |
MCHC (g/dl) | ||||||||||
Female | 30.8 (28.5–34.4) | 30.6 ± 1.2 | NA | NA | 33.9 (32.2–35.2) | NA | 34.2 (31.4–36.1) | NA | NA | NA |
Male | 31.3 (29.5–34.4) | 31.5 ± 1.3 | NA | NA | 34.2 (32.4–35.3) | NA | 34.6 (31.7–36.3) | NA | NA | NA |